In the research on malignant melanoma, it was found that CD9+ exosomes derived from CAFs have a significant inhibitory effect on the proliferation of malignant melanoma cells, and compared with CD9- patients, CD9+ patients have better disease-free survival rates (132). Here, CD9 is linked to melanoma.